Frank Tobin, MD
Dermatology · Phoenix, AZNPI 1275546533
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 755 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 755 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$703
- Regeneron Healthcare Solutions, Inc.$693
- Sanofi$558
- plus $6K from 36 others
What the payments were for
- Food & beverage$12,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$12,094 in reported general payments places this provider in the 85th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 55 | $2,497 |
| Tacrolimus | 13 | $1,949 |
| Cephalexin | 394 | $1,604 |
| Ketoconazole | 115 | $1,478 |
| Clindamycin Phosphate | 45 | $1,399 |
| Calcipotriene | 13 | $1,347 |
| Fluorouracil | 20 | $1,255 |
| Triamcinolone Acetonide | 96 | $1,069 |
| Doxycycline Hyclate | 83 | $842 |
| Nystatin | 57 | $638 |
| Imiquimod | 25 | $490 |
| Fluocinonide | 16 | $386 |
| Hydrocortisone | 70 | $374 |
| Ciclopirox | 14 | $252 |
| Mupirocin | 32 | $240 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Phoenix
- Lindsay AckermanPhoenix$1.6M
- Nathalie ZeitouniPhoenix$584K
- Carsten HamannPhoenix$364K
- Michael CrandallPhoenix$153K
- Sadra JazayeriPhoenix$115K
- Cynthia PricePhoenix$76K
- William KoPhoenix$66K
- Dathan HamannPhoenix$56K
- Peter SigalPhoenix$30K
- Xuan NguyenPhoenix$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.